DrugPatentWatch Database Preview

Deferiprone - Generic Drug Details

What are the generic sources for deferiprone and what is the scope of deferiprone patent protection?

Deferiprone is the generic ingredient in one branded drug marketed by Apopharma Inc and is included in two NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for deferiprone. One supplier is listed for this compound.

Summary for deferiprone

US Patents:	2
Tradenames:	1
Applicants:	1
NDAs:	2
Drug Master File Entries:	4
Suppliers / Packagers:	1
Bulk Api Vendors:	81
Clinical Trials:	53
Patent Applications:	1,032
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for deferiprone
DailyMed Link:	deferiprone at DailyMed

Pharmacology for deferiprone

Drug Class	Iron Chelator
Mechanism of Action	Iron Chelating Activity

Synonyms for deferiprone

1,2-dimethyl-3-hydroxy-4-pyridinone
1,2-dimethyl-3-hydroxy-4-pyridone
1,2-Dimethyl-3-hydroxy-4-pyridone, 99+%
1,2-DIMETHYL-3-HYDROXY-4-PYRIDONE,99+%
1,2-Dimethyl-3-hydroxy-4(1H)-pyridinone
1,2-Dimethyl-3-hydroxypyrid-4-one
1,2-Dimethyl-3-hydroxypyridine-4-one
1,2-dimetyl-3-hydroxy-4-pyridinone
2BTY8KH53L
3-HYDROXY-1,2-DIMETHYL-4 -PYRIDONE
3-hydroxy-1,2-dimethyl-4- pyridinone
3-Hydroxy-1,2-dimethyl-4-pyridinone
3-hydroxy-1,2-dimethyl-4(1H)-pyridinone
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone, 98%
3-Hydroxy-1,2-dimethyl-4(1H)pyridinone
3-hydroxy-1,2-dimethyl-pyridin-4-one
3-hydroxy-1,2-dimethylhydropyridin-4-one
3-hydroxy-1,2-dimethylpyrid-4-one
3-hydroxy-1,2-dimethylpyridin-4-one
3-hydroxy-1,2-dimethylpyridin-4(1H)-one
30652-11-0
3231AB
4(1H)-Pyridinone, 1,2-dimethyl-3-hydroxy-
4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl-
4(1H)-Pyridone, 3-hydroxy-1,2-dimethyl-
4(1H)-Pyridone, 3-hydroxy-1,2-dimethyl- (8CI)
AB00572605_11
AB00572605_12
AC1L1EVW
AC1Q3YW0
ACMC-209hhl
AJ-08273
AK112338
AKOS015902286
ANW-26935
API0002235
APO-066
APO-66
AX8010603
BB_SC-12066
BP-12415
BRN 1447108
C-01884
CAS-30652-11-0
CC-02933
CCG-100760
CCRIS 8318
CGP-37391
CHEBI:68554
CHEMBL70927
CP020
CP20
CP20 (Chelating agent)
CPD000059136
CRMD-001
CS-5240
D07416
D0N0OU
DB-047826
DB08826
deferione
deferiprone (dfp)
Deferiprone (INN)
Deferiprone (USAN/INN)
Deferiprone [BAN:INN]
Deferiprone [USAN:INN:BAN]
Deferum
DN-180-01-AF
DSSTox_CID_20666
DSSTox_GSID_40666
DSSTox_RID_79529
DTXSID6040666
EX-A972
FCH1115379
Ferriprox
Ferriprox (TN)
FT-0606424
GTPL7456
HE000683
HE196248
HK-1
HMS2051C05
HMS2232E24
HMS3264P17
HMS3393C05
HSDB 8335
HY-B0568
I14-13353
InChI=1/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3
KB-32094
KS-00000FAB
L-1[chelating agent]
L1
LS-133035
MCULE-6406005067
MFCD00134497
MLS000069481
MLS000758227
MLS001424029
MLS006011689
MolPort-001-792-505
NC00010
NCGC00090548-01
NCGC00090548-02
NSC-758880
NSC758880
Opera_ID_366
Pharmakon1600-01504512
PL1
s4067
SAM001247015
SBB006753
SBI-0207041.P001
SC-16614
SCHEMBL94474
SMR000059136
ST093416
ST24028539
TC-115680
Tox21_112429
TRA0004923
TZXKOCQBRNJULO-UHFFFAOYSA-
TZXKOCQBRNJULO-UHFFFAOYSA-N
UNII-2BTY8KH53L
VP13942
ZB000634
ZINC6226

US Patents and Regulatory Information for deferiprone

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apopharma Inc	FERRIPROX	deferiprone	SOLUTION;ORAL	208030-001	Sep 9, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Apopharma Inc	FERRIPROX	deferiprone	TABLET;ORAL	021825-001	Oct 14, 2011		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Apopharma Inc	FERRIPROX	deferiprone	TABLET;ORAL	021825-001	Oct 14, 2011		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Apopharma Inc	FERRIPROX	deferiprone	SOLUTION;ORAL	208030-002	Apr 20, 2018		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Apopharma Inc	FERRIPROX	deferiprone	SOLUTION;ORAL	208030-001	Sep 9, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Apopharma Inc	FERRIPROX	deferiprone	SOLUTION;ORAL	208030-001	Sep 9, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for deferiprone

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Portugal	1294379	➤ Sign Up
Australia	2001270402	➤ Sign Up
Spain	2539414	➤ Sign Up
Spain	2324978	➤ Sign Up
Israel	208876	➤ Sign Up
Brazil	0112280	➤ Sign Up
Canada	2313270	➤ Sign Up
Country	Document Number	Estimated Expiration